| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.29 | 6e-11 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-08 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-08 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-08 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-08 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.28 | 1e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.26 | 7e-07 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-06 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-06 |